Summit Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
3,912
+342
| +10% | +$152K | 0.1% | 128 |
|
|
2025
Q1 | $1.73M | Sell |
3,570
-1,407
| -28% | -$682K | 0.13% | 99 |
|
|
2024
Q4 | $2M | Sell |
4,977
-813
| -14% | -$327K | 0.13% | 130 |
|
|
2024
Q3 | $2.69M | Sell |
5,790
-3,829
| -40% | -$1.78M | 0.17% | 106 |
|
|
2024
Q2 | $4.51M | Sell |
9,619
-32,290
| -77% | -$15.1M | 0.3% | 71 |
|
|
2024
Q1 | $17.5M | Sell |
41,909
-32,679
| -44% | -$13.7M | 1.3% | 10 |
|
|
2023
Q4 | $30.3M | Buy |
74,588
+23,118
| +45% | +$9.41M | 1.99% | 7 |
|
|
2023
Q3 | $17.9M | Buy |
51,470
+46
| +0.1% | +$16K | 1.19% | 14 |
|
|
2023
Q2 | $18.1M | Sell |
51,424
-17,238
| -25% | -$6.07M | 1.2% | 11 |
|
|
2023
Q1 | $21.6M | Buy |
68,662
+273
| +0.4% | +$86K | 1.67% | 6 |
|
|
2022
Q4 | $19.7M | Sell |
68,389
-4,619
| -6% | -$1.33M | 1.67% | 7 |
|
|
2022
Q3 | $21.1M | Sell |
73,008
-7,841
| -10% | -$2.27M | 1.95% | 5 |
|
|
2022
Q2 | $22.8M | Sell |
80,849
-9,713
| -11% | -$2.74M | 2.01% | 3 |
|
|
2022
Q1 | $23.6M | Sell |
90,562
-4,482
| -5% | -$1.17M | 1.74% | 5 |
|
|
2021
Q4 | $20.9M | Buy |
+95,044
| New | +$20.9M | 1.34% | 17 |
|
|
2021
Q3 | – | Sell |
-5,007
| Closed | -$986K | – | 575 |
|
|
2021
Q2 | $986K | Sell |
5,007
-45,447
| -90% | -$8.95M | 0.06% | 235 |
|
|
2021
Q1 | $10.8M | Buy |
50,454
+20,657
| +69% | +$4.44M | 0.69% | 35 |
|
|
2020
Q4 | $7.04M | Buy |
29,797
+27,731
| +1,342% | +$6.55M | 0.7% | 33 |
|
|
2020
Q3 | $562K | Sell |
2,066
-18
| -0.9% | -$4.9K | 0.06% | 178 |
|
|
2020
Q2 | $605K | Buy |
+2,084
| New | +$605K | 0.07% | 175 |
|